Measurement of Left and Right Atria From CT Scans of Cardiac Rhythm Disorder Cases

Atrial Fibrillation Clinical Trial

Official title:

Measurement of Left and Right Atria From CT Scans of Cardiac Rhythm Disorder Cases

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01165593
• Other study ID #: H10-01337
• Status: Completed
• Phase: N/A
• First received: July 16, 2010
• Last updated: April 15, 2015
• Start date: November 2010
• Est. completion date: October 2013

Study information

• Verified date: April 2015
• Source: Kardium Inc.
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to gather information about the size and shape of patients' hearts in order to design a device.

Description:

Correct device design depends on getting good information about the shape and size of the different parts of the heart. Measurements from computed tomography images of hearts will be studied. By looking at measurements from a wide range of patients, an understanding of the differences in the size and shape of the heart chambers will be gained.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 96
• Est. completion date: October 2013
• Est. primary completion date: October 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients deemed suitable for treatment of atrial fibrillation by catheter-based ablation who have received cardiac CT imaging as part of normal care.

Exclusion Criteria:

• Patients who have not received cardiac CT imaging as part or normal care.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Arrhythmias, Cardiac
• Atrial Fibrillation

Intervention

Other:
• There is no intervention that is a part of this study.
There is no intervention that is a part of this study. Imaging data is gathered as part of normal care.

Locations

Country	Name	City	State
Canada	St. Paul's Hospital	Vancouver	British Columbia

Sponsors (2)

Lead Sponsor	Collaborator
Kardium Inc.	St. Paul's Hospital, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	LA size measurements		3 months	No